|
HS Code |
747305 |
| Chemical Name | 4-Bromo-2-iodopyridine |
| Cas Number | 40615-63-6 |
| Molecular Formula | C5H3BrIN |
| Molecular Weight | 299.89 g/mol |
| Appearance | Off-white to light yellow solid |
| Melting Point | 65-69°C |
| Density | 2.25 g/cm³ (approximate) |
| Solubility | Slightly soluble in water; soluble in organic solvents |
| Purity | Typically ≥97% |
| Synonyms | 2-Iodo-4-bromopyridine |
| Smiles | C1=CN=C(C=C1Br)I |
| Inchi | InChI=1S/C5H3BrIN/c6-4-1-2-8-5(7)3-4/h1-3H |
| Storage Conditions | Store at 2-8°C, keep dry and tightly sealed |
As an accredited 4-Bromo-2-iodopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A 5-gram amber glass bottle labeled "4-Bromo-2-iodopyridine," tightly sealed with a screw cap and hazard warning symbols. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 4-Bromo-2-iodopyridine involves secure, bulk packaging, ensuring safe transport, compliance, and efficient space utilization. |
| Shipping | Shipping of **4-Bromo-2-iodopyridine** requires adherence to regulations for hazardous chemicals. The compound should be securely packaged in chemically resistant containers, clearly labeled, and cushioned to prevent breakage. It must be shipped with proper documentation, following international transport rules for dangerous goods. Only authorized carriers should be used to ensure safety. |
| Storage | 4-Bromo-2-iodopyridine should be stored in a tightly closed container, protected from light and moisture, in a cool, dry, and well-ventilated area. It should be kept away from incompatible substances such as strong oxidizers. Proper labeling and use of secondary containment are recommended to prevent spills. Personal protective equipment should be used when handling this chemical. |
| Shelf Life | 4-Bromo-2-iodopyridine should be stored tightly sealed, protected from light and moisture; typical shelf life is 2–3 years under proper conditions. |
Competitive 4-Bromo-2-iodopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In the busy landscape of organic chemistry, certain building blocks attract more interest for what they offer to research and industrial laboratories. 4-Bromo-2-iodopyridine stands out for the straightforward reason that it combines two critical reactive sites on a single pyridine ring in a balanced, usable fashion. A chemist with an eye toward efficient design will spot its value right away, particularly in pharmaceutical synthesis or when setting up a new route for heterocyclic scaffolds. The positioning of both a bromine and an iodine atom on the same pyridine ring gives this molecule particular utility, as each halogen brings its own reactivity profile and compatibility with coupling reactions. The main appeal comes from the ease with which each position can be further manipulated by cross-coupling, nucleophilic substitution, or metalation, which offers a springboard for making tailored compounds much faster than traditional syntheses allow.
4-Bromo-2-iodopyridine is a pale, crystalline solid, with a molecular formula of C5H3BrIN. It weighs in at approximately 299.90 g/mol, reflecting its dual halogen substitutions. The 4-position bromine and 2-position iodine are spatially separated by nitrogen, minimizing unwanted side reactions and maximizing selectivity in subsequent transformations. This molecular configuration is not some quirky novelty — it solves real bottlenecks chemists run into when handling multi-step syntheses. In my experience, accessing analogs with mixed halides on a heterocycle saves entire days and sometimes weeks, especially in contract research labs running under strict deadlines.
What immediately sets 4-Bromo-2-iodopyridine apart is the combination of its two different halide sites. You get a very active C–I bond, which responds readily to palladium-catalyzed cross-coupling reactions like Suzuki and Sonogashira. The C–Br bond is slightly more inert but still offers a reactive handle for further derivatization under the right conditions. It’s almost like having a double-ended Swiss Army knife for organic synthesis, offering chemists efficient branching points in their route design. This flexibility matters when optimizing for both yield and purity, since fewer synthetic steps tend to mean fewer opportunities for error or contamination.
The real-world value of 4-Bromo-2-iodopyridine centers on what it lets chemists build. Heterocycles with carefully placed halogens serve as central elements in the pharmaceutical, agrochemical, and advanced material sectors. The unique reactivity of this compound opens doors to all sorts of C–C and C–N couplings. I’ve seen medicinal chemistry teams use it to prepare combinatorial libraries of kinase inhibitors, some of which make it further down the pipeline because the initial steps run smoothly — the right starting block cuts down on both cost and frustration. The synthesis of complex pyridine derivatives, especially those needed for patented drug scaffolds, becomes faster and more reliable with a bench stock of this intermediate on hand.
Having both bromine and iodine on the same ring reduces the burden of multiple protection and deprotection steps, which is still a thorny issue in many labs. Ask any bench chemist about the pain of protecting a functional group only to deprotect it later, and most will sigh in agreement. This compound lets researchers skip those steps, striking right at the heart of the molecule and building off exactly where it’s needed. It means more time spent on creative design of analogs, less time redoing routine protection chemistry. I recall a project aimed at making fluorinated pyridines, where having only a monohalogenated intermediate meant running three separate steps that could have been bypassed with a bifunctional starting point.
Single-halogen pyridines, such as 2-bromopyridine or 2-iodopyridine, have their place, but they don’t offer the versatility of this mixed halide version. Monohalo compounds limit sequential coupling or selective transformations. With single-halogen pyridines, building out diverse functional groups from a single molecule often involves retracing steps and driving up cost through repeated cycles. Using 4-Bromo-2-iodopyridine, you can tap into the high reactivity of the iodine and the more moderate activity of the bromine, scheduling your reactions for optimal selectivity.
For comparison, try coupling a plain bromopyridine versus an iodopyridine under identical Suzuki conditions. The iodopyridine reacts at a lower temperature, with higher yields and fewer byproducts — a difference that reverberates through every step that follows. With this mixed halide in your toolkit, you gain a type of molecular flexibility that single-halide compounds can’t provide. It allows researchers to install two different functional groups on a single core, spreading out the options for constructing more elaborated molecules in fewer steps.
Anyone who’s run a modern medicinal chemistry campaign knows the pressure to assemble ever more diversified libraries, usually under tight timeframes. 4-Bromo-2-iodopyridine brings major value to these workflows through cross-coupling reactions. Its C–I bond gets targeted first, typically through Suzuki, Sonogashira, or Stille couplings — all common in the discovery phase for rapid analog generation. You swap out the iodine, install a new aromatic or alkyne group, then double back to functionalize the bromine with less reactive partners.
This stepped approach lets research teams multiplex their efforts. You see ripple effects: fewer purification steps, less column time, a smaller solvent footprint, and more streamlined analytical workups. Anyone running a chemistry lab will recognize the cumulative impact in both time and resources. My own lab days always felt lighter when using bifunctional intermediates like this one, since it meant a shorter and cleaner synthetic pathway from start to target.
Outside pharmaceuticals, the compound plays a key role in making ligands for metal complexes and organic electronic materials. Pure pyridine derivatives are essential in the development of OLEDs, dyes, and advanced polymers. The ability to install complex substituents site-selectively has turned 4-Bromo-2-iodopyridine into a tool for researchers in these applications, especially when strict regiochemistry is required. Without it, researchers often fall back on longer, less direct synthetic routes, spending more time optimizing rather than discovering.
Scaling up any mixed halide intermediate brings its own challenges, most of which hinge on purity, stability, and reliable handling. Quality matters a great deal here, particularly with halogenated heterocycles — small impurities can derail sensitive coupling chemistry. Laboratories buying this molecule look for a well-characterized product, since trace metals and halide impurities will show up in every chromatogram down the line. The robust crystalline form and sharp melting point help, as does its manageable solubility in common organic solvents.
In an industrial setting, cost-effectiveness and reproducibility rule. With 4-Bromo-2-iodopyridine, the up-front expense often gets recovered by a major reduction in the number of synthetic steps and purification cycles. In my experience collaborating with process chemists, introducing such bifunctional reagents improves throughput in early-stage scale-up. Costs tied to waste handling and reprocessing fall, since you get to the final product with fewer intermediates, lower solvent consumption, and less energy use.
Every efficiency gained matters, both for bottom lines and for meeting sustainability goals. The more direct route enabled by this molecule helps pharmaceutical and fine chemical manufacturers hit deadlines and reduce their environmental footprint at the same time. I have seen entire process maps redrawn after switching from single-halogen to dual-halogen intermediates, and the result is always a tighter workflow with more predictable results.
Working with halogenated pyridines always comes with a set of safety and handling concerns. Both bromine and iodine substitutions mean extra care in weighing and transferring; solid handling under a fume hood is essential, and proper disposal of halide waste should never be overlooked. Product stability under storage is robust for 4-Bromo-2-iodopyridine, provided it remains dry and away from strong bases or oxidizers. Open-air exposure should be kept short to avoid any degradation.
Setting up reactions with this molecule, chemists working with palladium catalysis need to watch for potential catalyst poisoning from impurities in the starting material. High-purity lots help sidestep these problems. I recall one early project in which a poorly purified halopyridine led to stalling in a key cross-coupling step, wasting both time and expensive catalyst. Reliable supply chains and good analytical support on product batches — NMR, MS, and HPLC checks — reduce these headaches sharply.
Products like 4-Bromo-2-iodopyridine form the backbone of innovative synthesis yet often slip below the radar compared to big-ticket pharmaceutical APIs. From a buyer’s or researcher’s perspective, sourcing from reliable suppliers takes on real significance. I have seen substantial time and money lost because a cheap batch came with unreported contaminants or poor documentation. For critical building blocks, buyers expect transparent batch history and analytical data — high-resolution NMR, purity tests, and packaging that stands up to transport.
Supply chain transparency extends beyond simple trust. In regulated industries, compliance with environmental, health, and safety standards is a core expectation, not a bonus. Knowing exactly where a crucial intermediate originated, how it was produced, and how it was tested supports good manufacturing practice. Failures in documentation or quality can ripple downstream, causing regulatory complications or even product recalls. Having seen projects stall due to a single shipment issue, I put significant emphasis on working with suppliers known for robust traceability and batch support.
Several hurdles tend to crop up with heterocyclic halides, especially as batches scale from grams to kilos. One common issue is the formation of stubborn byproducts or isomers, which complicate purification. Careful reaction temperature control and fine-tuning of catalyst loads address these issues. In my network of process chemists, sharing data about solvent and reagent compatibility has streamlined troubleshooting. Open dialogue and pooling real-world experiences improves outcomes far more than simply following literature protocols.
Another pain point is the disposal of halogenated waste, which sometimes adds cost or regulatory overhead to a project. Green chemistry principles come into play here. Teams are exploring more use of recyclable solvents, continuous flow reactors, and more efficient ligands that lower scavenging costs. Adopting such strategies means less environmental burden and fewer regulatory headaches in the long run — wins not just for a chemistry department, but for broader business sustainability metrics.
Technical solutions also embrace automation. High-throughput screening of coupling conditions, in-line analytics, and automated purification mean researchers spend their time designing new targets, not waiting on slow conversions or painstaking column runs. Over the past decade, integrating such workflows with versatile intermediates like 4-Bromo-2-iodopyridine has modernized the day-to-day life of a synthetic chemist.
The environmental impact of halogenated reagents is a topic of real discussion in any industry that relies on organic synthesis. Chemical companies face growing pressure to minimize production waste, increase yields, and reduce hazardous byproducts. Compounds like 4-Bromo-2-iodopyridine, facilitating more efficient synthetic routes, form part of a practical solution. Cleaner, shorter sequences cut down on total waste and byproduct formation.
Industry standards now push toward green solvent use and energy reduction in all phases, from pilot lab to commercial plant. Some organizations support this shift by developing “greener” halopyridine production methods, employing catalytic systems with lower environmental burden and integrating renewable inputs wherever possible. As the business and scientific cases for environmental stewardship align, suppliers that invest in process improvement win loyalty from buyers seeking to future-proof their operations.
As I reflect on the constant evolution of synthetic chemistry, 4-Bromo-2-iodopyridine stands as proof that even “niche” intermediates can drive real progress. Its impact is visible in faster time-to-analog for pharmaceutical teams, leaner process maps for scale-up groups, and more reliable access to complex heterocyclic scaffolds. Its distinctive combination of halides all but erases the divide between bench chemists pursuing new discoveries and process teams building those successes on the scale required by industry.
Looking ahead, the ongoing refinement in cross-coupling techniques, recycling protocols, and real-time analytics will keep raising the bar for what users expect from this class of chemical intermediates. Researchers will keep asking for higher purity, more sustainable production methods, and tighter supply chain transparency. Suppliers who can consistently deliver in these areas will see their products become indispensable across more sectors, from drug discovery to flexible electronics. The pursuit of better, faster, and greener solutions starts with building blocks like 4-Bromo-2-iodopyridine — shaping not just the molecules on the bench, but the entire practice and business of chemistry.